ISOPI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 516
EU - Europa 311
AS - Asia 138
OC - Oceania 7
SA - Sud America 5
Totale 977
Nazione #
US - Stati Uniti d'America 499
IT - Italia 101
SG - Singapore 64
SE - Svezia 52
IE - Irlanda 50
CN - Cina 40
DE - Germania 23
UA - Ucraina 19
FR - Francia 16
CA - Canada 14
GB - Regno Unito 11
TR - Turchia 10
BE - Belgio 8
RU - Federazione Russa 8
AU - Australia 7
NL - Olanda 6
VN - Vietnam 6
BR - Brasile 5
ES - Italia 5
FI - Finlandia 5
IN - India 5
IR - Iran 4
KR - Corea 4
BZ - Belize 3
IL - Israele 2
JP - Giappone 2
PL - Polonia 2
CZ - Repubblica Ceca 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
Totale 977
Città #
Chandler 107
Singapore 56
Dublin 49
Ann Arbor 40
Ashburn 38
Jacksonville 32
Princeton 28
Chieti 25
Dearborn 21
Santa Clara 21
Houston 17
Montreal 13
New York 11
Altamura 10
Boardman 10
Rome 10
Wilmington 10
San Mateo 9
San Vito Chietino 9
Brussels 8
Washington 8
Woodbridge 8
Beijing 6
Dong Ket 6
Munich 6
Nanjing 6
Los Angeles 5
Ascoli Piceno 4
Izmir 4
Jiaxing 4
Jundiaí 4
Napoli 4
Rochester 4
Southend 4
Melbourne 3
Nuremberg 3
Saint-Saens 3
Tianjin 3
Amsterdam 2
Aprilia 2
Augusta 2
Bari 2
Cambridge 2
Helsinki 2
Lappeenranta 2
Milan 2
Nanchang 2
Ness Ziona 2
Ningbo 2
Pescara 2
Phoenix 2
Redwood City 2
Rotterdam 2
Rouen 2
San Cristóbal de La Laguna 2
Santander 2
Sinalunga 2
Tokyo 2
Woburn 2
Adelaide 1
Ankara 1
Antalya 1
Baotou 1
Belgrade 1
Brisbane 1
Cachan 1
Changsha 1
Charlotte 1
Clifton 1
Collecorvino 1
Denver 1
Edinburgh 1
Giresun 1
Haikou 1
Hebei 1
Heidelberg 1
Hoffman 1
Huzhou 1
Hwaseong-si 1
Jinan 1
Jinhua 1
Kunming 1
Kurrara 1
Lanciano 1
Lanzhou 1
Linyi 1
Lisbon 1
Norwalk 1
Oslo 1
Paderborn 1
Paris 1
Piotrkow Trybunalski 1
Pittsburgh 1
Prague 1
Prato 1
Pyatigorsk 1
Raleigh 1
Rio de Janeiro 1
San Juan 1
San Salvo 1
Totale 692
Nome #
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology 178
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 130
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 103
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 87
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 83
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 80
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 76
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis 69
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 66
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 65
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 56
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 51
Roles of specialized pro-resolving lipid mediators in autophagy and inflammation 33
Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction 12
Totale 1.089
Categoria #
all - tutte 4.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.425


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202080 0 0 0 0 11 14 22 5 2 7 15 4
2020/2021139 3 8 13 7 10 15 8 5 30 17 11 12
2021/2022133 5 7 1 28 9 1 4 11 6 6 22 33
2022/2023257 20 36 19 34 24 37 10 22 30 5 9 11
2023/2024184 5 6 11 9 14 37 18 25 6 23 16 14
2024/2025174 19 61 46 30 18 0 0 0 0 0 0 0
Totale 1.089